| Nov 12 |
CING: Third Quarter Results
|
| Nov 7 |
Cingulate reports Q3 results
|
| Nov 7 |
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
|
| Oct 8 |
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
|
| Sep 27 |
Cingulate files to sell 1.5M shares of common stock for holders
|
| Sep 12 |
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
|
| Aug 27 |
How Is The Market Feeling About Cingulate?
|
| Aug 26 |
CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage
|
| Aug 23 |
Cingulate Announces Adjournment of Special Meeting
|
| Aug 19 |
Top Midday Decliners
|
